Member Info for Newuncle

Old wives tales imo

Might be buyers on commission free broker?

Hi breq

Correct I kept to a conservative set of numbers just to get £40m ish revenues against £2 share price which I think would be a £400m mcap giving a ratio of 10:1 for revenue v mcap. I could be miles out in reality

CIRT PSE

2000 700

Jan 100 £200,000 1,000 £700,000 Total £900,000

Feb 125 £250,000 1,500 £1,050,000 Total £1,300,000

Mar 150 £300,000 2,000 £1,400,000 Total £1,700,000

Apr 175 £350,000 2,500 £1,750,000 Total £2,100,000

May 200 £400,000 3,000 £2,100,000 Total £2,500,000

Jun 225 £450,000 3,500 £2,450,000 Total £2,900,000

Jul 250 £500,000 4,000 £2,800,000 Total £3,300,000

Aug 275 £550,000 4,500 £3,150,000 Total £3,700,000

Sep 300 £600,000 5,000 £3,500,000 Total £4,100,000

Oct 325 £650,000 5,500 £3,850,000 Total £4,500,000

Nov 350 £700,000 6,000 £4,200,000 Total £4,900,000

Dec 375 £750,000 6,500 £4,550,000 Total £5,300,000

Total 2850 £5,700,000 45000 £31,500,000 Total £37,200,000

Is the following possible for 2024?

CIRT PSE

$2000 $700

100 £200,000 1,000 £700,000 £900,000

125 £250,000 1,500 £1,050,000 £1,300,000

150 £300,000 2,000 £1,400,000 £1,700,000

175 £350,000 2,500 £1,750,000 £2,100,000

200 £400,000 3,000 £2,100,000 £2,500,000

225 £450,000 3,500 £2,450,000 £2,900,000

250 £500,000 4,000 £2,800,000 £3,300,000

275 £550,000 4,500 £3,150,000 £3,700,000

300 £600,000 5,000 £3,500,000 £4,100,000

325 £650,000 5,500 £3,850,000 £4,500,000

350 £700,000 6,000 £4,200,000 £4,900,000

375 £750,000 6,500 £4,550,000 £5,300,000

Total £5,700,000 £31,500,000 £37,200,000

500,000 trades now, all BUYS so far.

125k trade looks like a buy

Small up tick on small buying volume, now lets see if buying continues or the sellers come in.

Fingers xxxd we see more buying.

The company’s flagship product, EpiSwitch CiRT (Checkpoint inhibitor Response Test), is a first-of-its-kind smart blood test for cancer patients that provides guidance on navigating the toughest challenges of immunotherapy like treatment planning, pseudo-progression, and adverse events. The company is partnering with CLIA-certified commercial labs to deliver these important tests into the hands of physicians to meet demand and help patients as quickly as possible.

EpiSwitch® in oncology

In September 2022, in a plenary talk at the European Society for Medical Oncology (ESMO) 2022 Congress entitled "Genomic biomarkers in peripheral blood from patients enrolled in the JAVELIN Bladder 100 trial of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (aUC)", renowned oncology expert Prof Thomas Powles (Director, Barts Cancer Centre) drew attention to the performance of OBD's EpiSwitch® biomarkers in an important clinical trial of avelumab, a leading ICI. In the presentation, co-authored with Pfizer, Prof Powles highlighted the benefits to clinical practice of including EpiSwitch® blood testing when predicting treatment response to avelumab.

The results themselves won't be important it's the forward looking comments that are 100% important. Not sure why no trading updates since previous results as income was pretty low then.

Seems like quite a few have had a 180 here, too many to name.

Looks like a sell

Buys outnumbered sells 4:1 today .

Interest is building

The same Tom forecast trac would be a £50m company, surely not?

900k buy.

Why you want to ban me?

No it was not

12-Jan-24 13:45:15 1.68 41,669 Buy* 1.6 1.7 700.04

12-Jan-24 13:44:11 1.67 100,000 Buy* 1.6 1.7 1,670

12-Jan-24 13:34:42 1.6 1,444 Sell* 1.6 1.7 23.1

12-Jan-24 12:50:19 1.61 5,000 Sell* 1.6 1.7 80.5

12-Jan-24 12:36:17 1.61 670 Sell* 1.6 1.7 10.79

12-Jan-24 11:44:24 1.64 62,294 Sell* 1.6 1.8 1,022

12-Jan-24 11:23:07 1.655 250,000 Sell* 1.6 1.8 4,138

12-Jan-24 10:30:58 1.651 36,795 Sell* 1.6 1.8 607.49

12-Jan-24 10:26:12 1.652 65,000 Sell* 1.6 1.8 1,074

11-Jan-24 15:27:30 1.74 29,083 Buy* 1.6 1.8 506.04

11-Jan-24 15:23:30 1.735 55,000 Buy* 1.6 1.8 954.25

11-Jan-24 15:22:08 1.7377 15,000 Buy* 1.6 1.8 260.66

11-Jan-24 15:04:31 1.7449 1 Buy* 1.6 1.8 0.02

LOFL it really is great comedy to watch Wobble publicly combusting here.

It's so obvious he is selling down CPX shares every day to keep the price depressed. as he hates us, the CEO and anything and everyone associated with CPX now. I have no idea just how many shares he had previously but I can can guarantee anyone he has far, far less shares here now and his campaign of hate will never end now but I shall enjoy his endless rantings.

Not its not a buy